Literature DB >> 31766050

Cryo-EM structures of apo and antagonist-bound human Cav3.1.

Yanyu Zhao1,2,3, Gaoxingyu Huang3, Qiurong Wu3, Kun Wu4, Ruiqi Li4, Jianlin Lei5, Xiaojing Pan3, Nieng Yan6,7.   

Abstract

Among the ten subtypes of mammalian voltage-gated calcium (Cav) channels, Cav3.1-Cav3.3 constitute the T-type, or the low-voltage-activated, subfamily, the abnormal activities of which are associated with epilepsy, psychiatric disorders and pain1-5. Here we report the cryo-electron microscopy structures of human Cav3.1 alone and in complex with a highly Cav3-selective blocker, Z9446,7, at resolutions of 3.3 Å and 3.1 Å, respectively. The arch-shaped Z944 molecule reclines in the central cavity of the pore domain, with the wide end inserting into the fenestration on the interface between repeats II and III, and the narrow end hanging above the intracellular gate like a plug. The structures provide the framework for comparative investigation of the distinct channel properties of different Cav subfamilies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31766050     DOI: 10.1038/s41586-019-1801-3

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  52 in total

1.  Current clamp and modeling studies of low-threshold calcium spikes in cells of the cat's lateral geniculate nucleus.

Authors:  X J Zhan; C L Cox; J Rinzel; S M Sherman
Journal:  J Neurophysiol       Date:  1999-05       Impact factor: 2.714

Review 2.  Molecular physiology of low-voltage-activated t-type calcium channels.

Authors:  Edward Perez-Reyes
Journal:  Physiol Rev       Date:  2003-01       Impact factor: 37.312

Review 3.  Calcium signaling.

Authors:  David E Clapham
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

4.  Dental therapy today. Occlusion and periodontal disease.

Authors:  M S Schwarz; P Sochat
Journal:  J South Calif Dent Assoc       Date:  1972-06

5.  [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].

Authors:  Z N Fedotova; I E Gur'ian; B I Kochetov
Journal:  Probl Tuberk       Date:  1972

6.  [Isolated pulmonary lymphogranulomatosis in children].

Authors:  B F Novikov
Journal:  Khirurgiia (Mosk)       Date:  1972-06

7.  Ca2+ channel selectivity at a single locus for high-affinity Ca2+ interactions.

Authors:  P T Ellinor; J Yang; W A Sather; J F Zhang; R W Tsien
Journal:  Neuron       Date:  1995-11       Impact factor: 17.173

8.  Electrophysiology of neurons of lateral thalamic nuclei in cat: resting properties and burst discharges.

Authors:  M Deschênes; M Paradis; J P Roy; M Steriade
Journal:  J Neurophysiol       Date:  1984-06       Impact factor: 2.714

9.  Aspartate residues of the Glu-Glu-Asp-Asp (EEDD) pore locus control selectivity and permeation of the T-type Ca(2+) channel alpha(1G).

Authors:  K Talavera; M Staes; A Janssens; N Klugbauer; G Droogmans; F Hofmann; B Nilius
Journal:  J Biol Chem       Date:  2001-08-28       Impact factor: 5.157

10.  Molecular determinants of Ca2+ selectivity and ion permeation in L-type Ca2+ channels.

Authors:  J Yang; P T Ellinor; W A Sather; J F Zhang; R W Tsien
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

View more
  32 in total

1.  Cyclic Peptides as T-Type Calcium Channel Blockers: Characterization and Molecular Mapping of the Binding Site.

Authors:  Anne-Sophie Depuydt; Jérôme Rihon; Olivier Cheneval; Michiel Vanmeert; Christina I Schroeder; David J Craik; Eveline Lescrinier; Steve Peigneur; Jan Tytgat
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-07

2.  CaV3.2 calcium channels: new players in facial pain.

Authors:  Kimberly Gomez; Rajesh Khanna
Journal:  Pain       Date:  2022-04-15       Impact factor: 7.926

3.  Employing NaChBac for cryo-EM analysis of toxin action on voltage-gated Na+ channels in nanodisc.

Authors:  Shuai Gao; William C Valinsky; Nguyen Cam On; Patrick R Houlihan; Qian Qu; Lei Liu; Xiaojing Pan; David E Clapham; Nieng Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

Review 4.  Presynaptic calcium channels: specialized control of synaptic neurotransmitter release.

Authors:  Annette C Dolphin; Amy Lee
Journal:  Nat Rev Neurosci       Date:  2020-03-11       Impact factor: 34.870

5.  Structural mechanisms of gating and selectivity of human rod CNGA1 channel.

Authors:  Jing Xue; Yan Han; Weizhong Zeng; Yan Wang; Youxing Jiang
Journal:  Neuron       Date:  2021-03-01       Impact factor: 17.173

6.  Seeking the exclusive binding region of phenylalkylamine derivatives on human T-type calcium channels via homology modeling and molecular dynamics simulation approach.

Authors:  You Lu; Ming Li; Gi Young Lee; Na Zhao; Zhong Chen; Andrea Edwards; Kun Zhang
Journal:  Pharmacol Res Perspect       Date:  2021-05

7.  Structure of the human sodium leak channel NALCN.

Authors:  Han Chow Chua; Cameron L Noland; Claudia Weidling; Marc Kschonsak; Thomas Clairfeuille; Oskar Ørts Bahlke; Aishat Oluwanifemi Ameen; Zhong Rong Li; Christopher P Arthur; Claudio Ciferri; Stephan Alexander Pless; Jian Payandeh
Journal:  Nature       Date:  2020-07-22       Impact factor: 49.962

8.  Structure of human Cav2.2 channel blocked by the painkiller ziconotide.

Authors:  Shuai Gao; Xia Yao; Nieng Yan
Journal:  Nature       Date:  2021-07-07       Impact factor: 49.962

9.  A modulator of the low-voltage-activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathies.

Authors:  Song Cai; Peter Tuohy; Chunlong Ma; Naoya Kitamura; Kimberly Gomez; Yuan Zhou; Dongzhi Ran; Shreya Sai Bellampalli; Jie Yu; Shizhen Luo; Angie Dorame; Nancy Yen Ngan Pham; Gabriella Molnar; John M Streicher; Marcel Patek; Samantha Perez-Miller; Aubin Moutal; Jun Wang; Rajesh Khanna
Journal:  Pain       Date:  2020-11       Impact factor: 7.926

Review 10.  Opioid Receptor Regulation of Neuronal Voltage-Gated Calcium Channels.

Authors:  Norbert Weiss; Gerald W Zamponi
Journal:  Cell Mol Neurobiol       Date:  2020-06-08       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.